For the Inventor, By the Inventor

Enter assignee name

Sunnyvale, CA, United States of America

Scios Inc.

USPTO Granted Patents = 82

% Expired Patents = 17.1

CIPO Patents = 2

EPO Patents = 6

Forward Citations = 1,612

Loading Chart...

Loading Chart...

89 inventors (with patents filed for the assignee):

Sundeep Dugar (21 out of 80 patents)

George Frederic Schreiner (20 out of 35 patents)

Babu J Mavunkel (19 out of 22 patents)

4. John J Perumattam (19 out of 19 patents)

5. John A Lewicki (19 out of 52 patents)

6. Sarvajit Chakravarty (16 out of 87 patents)

7. David Y Liu (13 out of 108 patents)

8. Qing Lu (10 out of 13 patents)

9. Barbara Cordell (10 out of 26 patents)

10. Gregory R Luedtke (8 out of 12 patents)

11. R Tyler White (8 out of 11 patents)

12. Lawrence W Stanton (7 out of 8 patents)

13. Robert M Scarborough (6 out of 153 patents)

14. J Jeffrey Seilhamer (6 out of 6 patents)

15. J Gordon Porter (6 out of 7 patents)

Core Competencies:

Natriuretic Peptides

P38 Kinase

Cardiac Failure

Quinazoline Derivatives

Osteogenesis

Vascular Endothelial Growth Factor

Bradykinin Antagonists

Neuronal Degeneration

Growth Factors

Fibroblast Growth Factor

Aβ-Secretase

Gene Expression

82 patents: Sort by Forward Citations

1. 9482677 - Method, composition and device for sampling natriuretic peptides in a biological fluid (2016-11-01),

2. 7488744 - Indole-type derivatives as inhibitors of p38 kinase (2009-02-10),

3. 7393851 - Azaindole derivatives as inhibitors of p38 kinase (2008-07-01),

4. 7345045 - Pyrido-pyrimidine compounds as medicaments (2008-03-18),

5. 7304048 - Indole-type derivatives as inhibitors of p38 kinase (2007-12-04),

6. 7291613 - Inhibitors of p38 kinase (2007-11-06),

7. 7268139 - Methods of promoting osteogenesis (2007-09-11),

8. 7244441 - Stents and intra-luminal prostheses containing map kinase inhibitors (2007-07-17),

9. 7238712 - Indole-type derivatives as inhibitors of p38 kinase (2007-07-03),

10. 7232824 - Quinazoline derivatives as medicaments (2007-06-19),

11. 7223766 - Bi-cyclic pyrimidine inhibitors of TGFβ (2007-05-29),

12. 7220763 - Indole-type derivatives as inhibitors of p38 kinase (2007-05-22),

13. 7214679 - Piperidine/piperazine-type inhibitors of p38 kinase (2007-05-08),

14. 7202344 - Secreted factors (2007-04-10),

15. 7189739 - Compounds and methods to treat cardiac failure and other disorders (2007-03-13),

Scios Inc., based in Sunnyvale, California, specializes in the development of innovative kinase inhibitors with a focus on addressing critical health issues such as cardiac failure and neuronal degeneration. The company leverages advanced research in natriuretic peptides, P38 kinase, and quinazoline derivatives to create therapeutic solutions. Additionally, Scios explores the roles of vascular endothelial growth factor and bradykinin antagonists in its drug development efforts, aiming to improve patient outcomes in various medical conditions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

82 Patents

#60 in Sunnyvale, CA

#1,048 in California

#4,525 in US

#9,254 in the World

Sunnyvale, CA, United States of America

Scios Inc.

Forward Citations = 1,612

89 inventors:

Sundeep Dugar (21 out of 80 patents)

George Frederic Schreiner (20 out of 35 patents)

Babu J Mavunkel (19 out of 22 patents)

4. John J Perumattam (19 out of 19 patents)

5. John A Lewicki (19 out of 52 patents)

Please report any incorrect information to [email protected]

Loading…